Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Mylan Pharms. Inc. v. Shire Labs., Inc., IPR2017-00011 (PTAB) Oct. 4, 2016 N/A Adderall XR® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) RE41,148
Amgen Inc. v. Ajanta Pharma Ltd., 16-0899 (D. Del.) Oct. 5, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Dr. Reddy’s Labs., Ltd., 16-0900 (D. Del.) Oct. 5, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
UCB, Inc. v. Zydus Pharms. (USA) Inc., 16-0903 (D. Del.) Oct. 6, 2016 Hon. Leonard P. Stark Vimpat® (lacosamide for injection) RE38,551
Astellas Pharma Inc. v. Actavis Elizabeth LLC, 16-0905 (D. Del.) Oct. 6, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 6,346,532, 7,342,117, 7,982,049, 8,835,474, RE44,872
Alcon Research, Ltd. v. Apotex Inc., 16-0906 (D. Del.) Oct. 6, 2016 Hon. Sue L. Robinson Pazeo® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Astellas Pharma Inc. v. Lupin Ltd., 16-0908 (D. Del.) Oct. 7, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Alza Corp. v. Amneal Pharms. of New York, LLC, 16-0914 (D. Del.) Oct. 7, 2016 Hon. Richard G. Andrews Concerta® (methylphenidate hydrochloride tablets) 8,163,798, 9,144,549
Forest Labs., LLC v. Amerigen Pharms., Inc., 16-0917 (D. Del.) Oct. 7, 2016 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules) 8,039,009, 8,058,291, 8,168,209, 8,173,708, 8,283,379, 8,293,794, 8,329,752, 8,338,485, 8,338,486, 8,362,085, 8,580,858, 8,598,233
Alcon Pharms. Ltd. v. Dr. Reddy’s Labs., Inc., 16-6775 (D.N.J.) Oct. 7, 2016 Hon. Peter G. Sheridan Ciprodex® (ciprofloxacin / dexamethasone otic suspension) 9,402,805
Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, IPR2017-00041 (PTAB) Oct. 7, 2016 N/A Xarelto® (rivaroxaban tablets) 7,157,456
Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, IPR2017-00042 (PTAB) Oct. 7, 2016 N/A Xarelto® (rivaroxaban tablets) 7,585,860
Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, IPR2017-00043 (PTAB) Oct. 7, 2016 N/A Xarelto® (rivaroxaban tablets) 7,592,339
Astellas Pharma Inc. v. Zydus Pharms. (USA), Inc., 16-0924 (D. Del.) Oct. 11, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Amgen Inc. v. Amneal Pharms. LLC, 16-0925 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Apotex Inc., 16-0926 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Breckenridge Pharm. Inc., 16-0927 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Hetero USA Inc., 16-0928 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Astellas Pharma Inc. v. Windlas Healthcare, Pvt. Ltd., 16-0930 (D. Del.) Oct. 12, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Astellas Pharma Inc. v. Aurobindo Pharma Ltd., 16-0942 (D. Del.) Oct. 13, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Astellas Pharma Inc. v. Prinston Pharm. Inc., 16-0943 (D. Del.) Oct. 13, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution, Inc., 16-0944 (D. Del.) Oct. 13, 2016 Hon. Gregory M. Sleet Inomax® (nitric oxide for inhalation) 9,408,993
Astellas Pharma Inc. v. Sandoz Inc., 16-0952 (D. Del.) Oct. 14, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
AstraZeneca AB v. Glenmark Pharms. Ltd., 16-7330 (D.N.J.) Oct. 14, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules) 6,369,085, 7,411,070, 8,466,175
Otsuka Pharm. Co., Ltd. v. Stason Indus. Corp., 16-7346 (D.N.J.) Oct. 14, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Astellas Pharma Inc. v. Sawai Pharm. Co., Ltd., 16-0954 (D. Del.) Oct. 17, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 6,346,532, 7,342,117, 7,982,049, 8,835,474, RE44,872
Celgene Corp. v. Dr. Reddy’s Labs., Ltd., 16-7704 (D.N.J.) Oct. 20, 2016 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,465,800, 7,855,217, 7,968,569, 8,530,498, 8,648,095, 9,101,621, 9,101,622
Astellas Pharma Inc. v. Apotex Inc., 16-0976 (D. Del.) Oct. 21, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 16-7705 (D.N.J.) Oct. 21, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., 16-7721 (D.N.J.) Oct. 21, 2016 Hon. Jose L. Linares Narcan® (naloxone hydrochloride nasal spray) 9,211,253
Takeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc., 16-0987 (D. Del.) Oct. 24, 2016 Hon. Sue L. Robinson Colcrys® (colchicine tablets) 7,906,519, 7,935,731, 8,093,298, 7,964,648, 8,093,297, 7,619,004, 7,601,758, 7,820,681, 7,915,269, 7,964,647, 7,981,938, 8,093,296, 8,097,655, 8,415,395, 8,415,396, 8,440,721, 8,440,722
Onyx Therapeutics, Inc. v. Cipla Ltd., 16-0988 (D. Del.) Oct. 24, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Takeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc., 16-0202 (N.D.W.V.) Oct. 25, 2016 Hon. Irene M. Keeley Colcrys® (colchicine tablets) 7,906,519, 7,935,731, 8,093,298, 7,964,648, 8,093,297, 7,619,004, 7,601,758, 7,820,681, 7,915,269, 7,964,647, 7,981,938, 8,093,296, 8,097,655, 8,415,395, 8,415,396, 8,440,721, 8,440,722
Millennium Pharms., Inc. v. Hospira, Inc., 16-0998 (D. Del.) Oct. 26, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446
Onyx Therapeutics, Inc. v. MSN Pharms., Inc., 16-0999 (D. Del.) Oct. 26, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Onyx Therapeutics, Inc. v. Sagent Pharms., Inc., 16-1000 (D. Del.) Oct. 26, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Eli Lilly and Co. v. Cipla Ltd., 16-2911 (S.D. Ind.) Oct. 26, 2016 Hon. Richard L. Young Axiron® (testosterone metered transdermal solution) 8,435,944, 8,993,520, 9,180,194
Onyx Therapeutics, Inc. v. Breckenridge Pharm., Inc., 16-1001 (D. Del.) Oct. 27, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Galderma Labs., L.P. v. Sun Pharm. Indus. Ltd., 16-1003 (D. Del.) Oct. 27, 2016 Hon. Leonard P. Stark Oracea® (doxycycline tablets) 7,211,267, 7,232,572, 8,603,506, 7,749,532, 8,206,740, 8,394,405, 8,394,406, 8,470,364, 8,709,478, 9,241,946
Eli Lilly and Co. v. Cipla Ltd., 16-1005 (D. Del.) Oct. 28, 2016 Hon. Sue L. Robinson Axiron® (testosterone metered transdermal solution) 8,435,944, 8,993,520, 9,180,194
Eli Lilly and Co. v. Accord Healthcare, Inc., 16-1352 (E.D. Va.) Oct. 28, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
Indivior Inc. v. Actavis Labs. UT, Inc., 16-1009 (D. Del.) Oct. 31, 2016 Hon. Richard G. Andrews Suboxone® (buprenorphine / naloxone sublingual film) 8,475,832, 8,017,150, 8,603,514
Otsuka Pharm. Co., Ltd. v. Indoco Remedies Ltd., 16-8085 (D.N.J.) Oct. 31, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302, 9,387,182
Amarin Pharma, Inc. v. Roxane Labs., Inc., 16-2525 (D. Nev.) Oct. 31, 2016 Hon. Miranda M. Du Vascepa® (icosapent ethyl capsules) 8,293,728, 8,318,715, 8,357,677, 8,367,652, 8,377,920, 8,399,446, 8,415,335, 8,426,399, 8,431,560, 8,440,650, 8,518,929, 8,524,698, 8,546,372, 8,617,594
Onyx Therapeutics, Inc. v. Dr. Reddy’s Labs., Inc., 16-1011 (D. Del.) Nov. 1, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Onyx Therapeutics, Inc. v. Fresenius Kabi USA, LLC, 16-1012 (D. Del.) Nov. 1, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Onyx Therapeutics, Inc. v. Qilu Pharma, Inc., 16-1013 (D. Del.) Nov. 1, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Eli Lilly and Co. v. Fresenius Kabi USA, LLC, 16-2960 (S.D. Ind.) Nov. 1, 2016 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium for injection) 7,772,209
Acrux DDS Pty Ltd. v. Kaken Pharm. Co., Ltd., IPR2017-00190 (PTAB) Nov. 2, 2016 N/A Jublia® (efinaconazole topical solution) 7,214,506
Mylan Pharms. Inc. v. Yeda Research & Development Co., Ltd., IPR2017-00195 (PTAB) Nov. 2, 2016 N/A Copaxone® (glatiramer acetate injection) 9,155,776
UCB, Inc. v. Zydus Worldwide DMCC, 16-1023 (D. Del.) Nov. 3, 2016 Hon. Sue L. Robinson Neupro® (rotigotine transdermal system) 8,246,979, 8,246,980, 8,617,591, 6,884,434
Medicis Pharm. Corp. v. Dr. Reddy’s Labs., Ltd., 16-8282 (D.N.J.) Nov. 4, 2016 Hon. Brian R. Martinotti Solodyn® (minocycline hydrochloride extended-release tablets) 5,908,838, 7,790,705, 7,919,483, 8,252,776, 8,268,804, 8,722,650
Otsuka Pharm. Co., Ltd. v. Zhejiang Huahai Pharm. Co., Ltd., 16-8284 (D.N.J.) Nov. 4, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302, 9,387,182
Amarin Pharma, Inc. v. Dr. Reddy’s Labs., Inc., 16-2562 (D. Nev.) Nov. 4, 2016 Hon. Robert C. Jones Vascepa® (icosapent ethyl capsules) 8,293,728, 8,318,715, 8,357,677, 8,367,652, 8,377,920, 8,399,446, 8,415,335, 8,426,399, 8,431,560, 8,440,650, 8,518,929, 8,524,698, 8,546,372, 8,617,594
Mylan Technologies, Inc. v. Monosol Rx, LLC, IPR2017-00200 (PTAB) Nov. 4, 2016 N/A Suboxone® (buprenorphine / naloxone sublingual film) 8,603,514
Mylan Pharms. Inc. v. Qualicaps Co.Ltd, IPR2017-00203 (PTAB) Nov. 4, 2016 N/A Delzicol® (mesalamine delayed-release capsule) 6,649,180
Onyx Therapeutics, Inc. v. InnoPharma, Inc., 16-1036 (D. Del.) Nov. 8, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,737,112, 8,207,297
Onyx Therapeutics, Inc. v. Apotex Inc., 16-1039 (D. Del.) Nov. 8, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Forest Labs., LLC v. Apotex Corp., 16-1045 (D. Del.) Nov. 10, 2016 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules) 8,039,009, 8,058,291, 8,338,485, 8,338,486, 8,580,858
Alcon Research, Ltd. v. Akorn, Inc., 16-3092 (S.D. Ind.) Nov. 11, 2016 Hon. Jane Magnus-Stinson Pataday® (olopatadine hydrochloride ophthalmic solution) 6,995,186, 7,402,609
The Medicines Co. v. Akorn, Inc., 16-8546 (D.N.J.) Nov. 15, 2016 Hon. Peter G. Sheridan Angiomax® (bivaluirudin for injection) 7,582,727, 7,598,343
United Therapeutics Corp. v. Par Sterile Products, LLC, 16-8548 (D.N.J.) Nov. 16, 2016 Hon. Peter G. Sheridan Remodulin® (treprostinil sodium for injection) 8,497,393, 9,199,908, 7,999,007, 8,653,137, 8,658,694
United Therapeutics Corp. v. Par Sterile Products, LLC, 16-1066 (D. Del.) Nov. 17, 2016 Hon. Sue L. Robinson Remodulin® (treprostinil sodium for injection) 8,497,393, 9,199,908, 7,999,007, 8,653,137, 8,658,694
Apotex Inc. v. Alcon Research, Ltd., 16-3145 (S.D. Ind.) Nov. 17, 2016 Hon. William T. Lawrence Pataday® (olopatadine hydrochloride ophthalmic solution) 6,995,186, 7,402,609
Alkermes Pharma Ireland Ltd. v. Otsuka Pharm. Co., Ltd., IPR2017-00287 (PTAB) Nov. 17, 2016 N/A Abilify® (aripiprazole tablets) 9,125,939
Aptalis Pharma Canada ULC v. Par Pharm., Inc., 16-1069 (D. Del.) Nov. 18, 2016 Hon. Sue L. Robinson Pylera® (bismuth subcitrate potassium / metronidazole / tetracycline hydrochloride capsules) 6,350,468
Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 16-2658 (D. Nev.) Nov. 18, 2016 Hon. Miranda M. Du Vascepa® (icosapent ethyl capsules) 8,293,728, 8,318,715, 8,357,677, 8,367,652, 8,377,920, 8,399,446, 8,415,335, 8,426,399, 8,431,560, 8,440,650, 8,518,929, 8,524,698, 8,546,372, 8,617,594
Mylan Pharms. Inc. v. Icos Corp., IPR2017-00323 (PTAB) Nov. 22, 2016 N/A Cialis® (tadalafil tablets) 6,943,166
Merck, Sharp & Dohme Corp. v. Strides Pharma Inc., 16-8850 (D.N.J.) Nov. 29, 2016 Hon. Brian R. Martinotti Sustiva® (efavirenz tablets) 6,639,071, 6,939,964, 6,673,372
Forest Labs., LLC v. Teva Pharms. USA, Inc., 16-1114 (D. Del.) Nov. 30, 2016 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 7,304,036, 7,371,727, 7,704,947, 7,745,409, 8,080,526, 8,110,553, 8,748,573, 8,802,628, 8,933,030
Eli Lilly and Co. v. Apotex, Inc., 16-0941 (E.D. Va.) Nov. 30, 2016 Hon. M. Hannah Lauck Cialis® (tadalafil tablets) 6,943,166
Mallinckrodt IP v. Mylan Labs. Ltd., 16-1115 (D. Del.) Dec. 1, 2016 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 6,028,222, 6,992,218
Malinckrodt IP v. Innopharma Licensing LLC, 16-1116 (D. Del.) Dec. 1, 2016 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012
Astellas Pharma Inc. v. Actavis Labs. FL, Inc., 16-1120 (D. Del.) Dec. 2, 2016 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517, 8,183,274, 9,126,941
Merck, Sharp & Dohme Corp. v. Aurobindo Pharma Ltd., 16-9033 (D.N.J.) Dec. 6, 2016 Hon. Brian R. Martinotti Sustiva® (efavirenz tablets) 6,639,071, 6,939,964, 6,673,372
Horizon Pharma, Inc. v. Dr. Reddy’s Labs. Inc., 16-9035 (D.N.J.) Dec. 6, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 9,393,208
Valeant Pharms. Int’l, Inc. v. Actavis Labs. FL, Inc., 16-9038 (D.N.J.) Dec. 6, 2016 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide tablets) 8,420,663, 8,524,276, 8,956,651, 9,180,125, 9,314,461
MonoSol Rx, LLC v. Icos Corp., IPR2017-00412 (PTAB) Dec. 6, 2016 N/A Cialis® (tadalafil tablets) 6,943,166
Orexo AB v. Actavis Elizabeth LLC, 16-1138 (D. Del.) Dec. 7, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets) 9,439,900
Orexo AB v. Actavis Elizabeth LLC, 16-1139 (D. Del.) Dec. 7, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets) 9,439,900
Abraxis Bioscience, LLC v. Cipla Ltd., 16-9074 (D.N.J.) Dec. 7, 2016 Hon. John Michael Vazquez Abraxane® (paclitaxel protein-bound particles for injectable suspension) 7,820,788, 7,923,536, 8,138,229, 8,853,260
Astellas Pharma Inc. v. Apotex Inc., 16-1166 (D. Del.) Dec. 9, 2016 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517, 8,183,274, 9,126,941
Astellas Pharma Inc. v. Zydus Pharms. (USA) Inc., 16-1167 (D. Del.) Dec. 9, 2016 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517, 8,183,274, 9,126,941
Apicore US LLC v. Pfizer Inc., 16-1174 (D. Del.) Dec. 12, 2016 Hon. Sue L. Robinson Tikosyn® (dofetilide capsules) 6,124,363
Eli Lilly and Co. v. Ajanta Pharma, Ltd., 16-0714 (E.D. Va.) Dec. 13, 2016 Hon. Mark S. Davis Cialis® (tadalafil tablets) 6,943,166
Bayer Healthcare LLC v. Teva Pharms. USA, Inc., 16-1220 (D. Del.) Dec. 16, 2016 Hon. Leonard P. Stark Nexavar (sorafenib tosylate tablets) 8,877,933
Bayer Healthcare LLC v. Teva Pharms. USA, Inc., 16-1221 (D. Del.) Dec. 16, 2016 Hon. Leonard P. Stark Stivarga® (regorafenib tablets) 7,351,834, 8,637,553, 8,680,124, 9,458,107
Bayer Healthcare LLC v. Apotex, Inc., 16-1222 (D. Del.) Dec. 16, 2016 Hon. Leonard P. Stark Stivarga® (regorafenib tablets) 8,637,553
Millennium Pharms., Inc. v. MSN Labs. Private Ltd., 16-1255 (D. Del.) Dec. 19, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446, 6,958,319
Teva Pharms. USA, Inc. v. Dr. Reddy’s Labs., Ltd., 16-1267 (D. Del.) Dec. 19, 2016 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate injection) 9,402,874
Impax Labs., Inc. v. Actavis Labs. FL, Inc., 16-9416 (D.N.J.) Dec. 20, 2016 Hon. Stanley R. Chesler Rytary® (levodopa / carbidopa extended-release capsules) 9,463,246
Eli Lilly and Co. v. Hospira, Inc., 16-3460 (S.D. Ind.) Dec. 21, 2016 Hon. Sarah Evans Barker Alimta® (pemetrexed disodium for injection) 7,772,209
Sanofi-Aventis U.S. LLC v. Watson Labs., Inc., 16-1298 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Aurobindo Pharma USA, Inc., 16-1299 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Alvogen Pine Brook LLC, 16-1300 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Biodelivery Sciences Int’l, Inc. v. Teva Pharms. USA, Inc., 16-1303 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Belbuca® (buprenorphine buccal film) 7,579,019, 8,147,866
Allergan, Inc. v. Deva Holding A.S., 16-1447 (E.D. Tex.) Dec. 22, 2016 Hon. Robert W. Schroeder, III Restasis® (cyclosporine ophthalmic emulsion) 8,629,111, 8,633,162, 8,642,556, 8,648,048, 8,685,930, 9,248,191
Wyeth LLC v. Alembic Pharms., Ltd., 16-1305 (D. Del.) Dec. 23, 2016 Hon. Richard G. Andrews Bosulif® (bosutinib tablets) 7,417,148, 7,767,678
Rhodes Pharms. L.P. v. Indivior Inc., 16-1308 (D. Del.) Dec. 23, 2016 Hon. Sue L. Robinson Suboxone® (buprenorphine / naloxone sublingual film) 9,370,512
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 16-1311 (D. Del.) Dec. 27, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Apotex, Inc., 16-1312 (D. Del.) Dec. 27, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Alembic Pharms. Ltd., 16-1316 (D. Del.) Dec. 28, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Glenmark Pharms. Inc., USA, 16-1326 (D. Del.) Dec. 29, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
AstraZeneca AB v. Cipla Ltd., 16-9583 (D.N.J.) Dec. 29, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules) 6,369,085, 7,411,070
Sanofi-Aventis U.S. LLC v. Emcure Pharms. Ltd., 16-1330 (D. Del.) Dec. 30, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 9,186,346
Sanofi-Aventis U.S. LLC v. Torrent Pharma Inc., 16-1333 (D. Del.) Dec. 30, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Otsuka Pharm. Co., Ltd. v. Orchid Pharma Ltd., 16-9603 (D.N.J.) Dec. 30, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,358,207

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.